English | Español

Regulatory
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Regulatory
Patient Daily | Aug 4, 2026

American Association of Nurse Practitioners announces 2026 National NP Week events and resources
+ Regulatory
L. R. Alvarez | Jul 30, 2026

TPA's Ross Marchand on 340B: 'Taxpayers are picking up the tab for the program's many failures and mission creep'
+ Regulatory
J. R. Bair | Jul 28, 2026

Employers for Hospital Accountability: 'Participating hospitals are stockpiling far more assets than similar non-340B hospitals'
+ Regulatory
F. M. Arthur | Jul 27, 2026

AIR340B: 'Across the nation, large, tax-exempt hospitals are exploiting the 340B program'
+ Regulatory
Patient Daily | Jul 24, 2026

AANP extends online conference deadline, offers expanded continuing education for nurse practitioners
+ Regulatory
H. P. Fulton | Jul 22, 2026

APCI: TRICARE beneficiaries deserve to fill prescriptions at trusted pharmacies, not 'line the pockets of a PBM'

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes